Omega 3 Fatty Acids Promote Macrophage Reverse Cholesterol Transport in Hamster Fed High Fat Diet

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kasbi Chadli, Fatima ^a,b,c   Nazih, Hassane ^c,d   Krempf, Michel ^a,c   Nguyen, Patrick ^b,c   Ouguerram, Khadija ^a,c  

^a L INSTITUT DU THORAX   (France)

^b LUNAM UNIVERSITÉ   (France)

^c CRNH AUVERGNE   (France)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CD36 ANTIGEN; CHOLESTEROL;

ABCA1 GENE; ABCG1 GENE; ABCG5 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYP7A1 GENE; ENZYME ACTIVITY; FECES LEVEL; GENE; GENE EXPRESSION; HAMSTER; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MACROPHAGE FUNCTION; MACROPHAGE REVERSE CHOLESTEROL TRANSPORT; MALE; NONHUMAN; PROTEIN EXPRESSION; SR B1 GENE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; DIET SUPPLEMENTATION; DRUG EFFECTS; FECES; MACROPHAGE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

CRICETINAE;

ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CRICETINAE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FECES; MACROPHAGES; MALE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 84876430244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061109     Document Type: Article

References (58)

1. Ginsberg HN, Zhang YL, Hernandez-Ono A, (2006) Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring) 14 Suppl 1: 41S-49S.
2. Calabresi L, Sirtori CR, Paoletti R, Franceschini G, (2006) Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases. Curr Atheroscler Rep 8: 163-167.
3. Sakai N, Yamashita S, Hirano K, Menju M, Arai T, et al. (1995) Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis 114: 139-145.
4. deGoma EM, deGoma RL, Rader DJ, (2008) Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 51: 2199-2211.
5. Nishimoto T, Pellizzon MA, Aihara M, Stylianou IM, Billheimer JT, et al. (2009) Fish oil promotes macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol 29: 1502-1508.
6. nTanigawa H, Billheimer JT, Tohyama J, Zhang Y, Rothblat G, et al. (2007) Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 116: 1267-1273.
7. Ouguerram K, Krempf M, Maugeais C, Maugere P, Darmaun D, et al. (2002) A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans. Metabolism 51: 5-11.
8. Briand F, (2010) The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport. Curr Opin Investig Drugs 11: 289-297.
9. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090-1098.
10. Harrison N, Abhyankar B, (2005) The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction. Curr Med Res Opin 21: 95-100.
11. Kasbi Chadli F, Andre A, Prieur X, Loirand G, Meynier A, et al. (2011) n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet. Br J Nutr pp. 1-11.
12. Nagasaki T, Akanuma Y, (1977) A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity. Clin Chim Acta 75: 371-375.
13. Treguier M, Briand F, Boubacar A, Andre A, Magot T, et al. (2011) Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters. Eur J Clin Invest.
14. Ripolles Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, et al. (2006) Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism 55: 980-988.
15. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
16. Castro-Perez J, Briand F, Gagen K, Wang SP, Chen Y, et al. (2011) Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters. J Lipid Res 52: 1965-1973.
17. Tchoua U, D'Souza W, Mukhamedova N, Blum D, Niesor E, et al. (2008) The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Cardiovasc Res 77: 732-739.
18. Bernard DW, Rodriguez A, Rothblat GH, Glick JM, (1991) cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages. J Biol Chem 266: 710-716.
19. Mazzone T, Reardon C, (1994) Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. J Lipid Res 35: 1345-1353.
20. Okuno M, Kajiwara K, Imai S, Kobayashi T, Honma N, et al. (1997) Perilla oil prevents the excessive growth of visceral adipose tissue in rats by down-regulating adipocyte differentiation. J Nutr 127: 1752-1757.
21. Rossmeisl M, Jelenik T, Jilkova Z, Slamova K, Kus V, et al. (2009) Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Obesity (Silver Spring) 17: 1023-1031.
22. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, et al. (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99: 11482-11486.
23. le Morvan V, Dumon MF, Palos-Pinto A, Berard AM, (2002) n-3 FA increase liver uptake of HDL-cholesterol in mice. Lipids 37: 767-772.
24. Spady DK, Kearney DM, Hobbs HH, (1999) Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res 40: 1384-1394.
25. Hassanali Z, Ametaj BN, Field CJ, Proctor SD, Vine DF, (2010) Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab 12: 139-147.
26. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, et al. (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93: 243-252.
27. Harris W, (2010) Omega-6 and omega-3 fatty acids: partners in prevention. Curr Opin Clin Nutr Metab Care 13: 125-129.
28. Ouguerram K, Maugeais C, Gardette J, Magot T, Krempf M, (2006) Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects. Br J Nutr 96: 100-106.
29. Ozasa H, Ayaori M, Iizuka M, Terao Y, Uto-Kondo H, et al. (2011) Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway: findings from in vitro and ex vivo studies. Atherosclerosis 219: 141-150.
30. Montoya MT, Porres A, Serrano S, Fruchart JC, Mata P, et al. (2002) Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity. Am J Clin Nutr 75: 484-491.
31. Ottestad I, Hassani S, Borge GI, Kohler A, Vogt G, et al. (2012) Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects. PLoS One 7: e42550.
32. Davidson WS, Gillotte KL, Lund-Katz S, Johnson WJ, Rothblat GH, et al. (1995) The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem 270: 5882-5890.
33. Holzer M, Wolf P, Curcic S, Birner-Gruenberger R, Weger W, et al. (2012) Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res 53: 1618-1624.
34. Fournier N, Atger V, Cogny A, Vedie B, Giral P, et al. (2001) Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 157: 315-323.
35. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT, (2009) Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 16: 163-171.
36. Sheril A, Jeyakumar SM, Jayashree T, Giridharan NV, Vajreswari A, (2009) Impact of feeding polyunsaturated fatty acids on cholesterol metabolism of dyslipidemic obese rats of WNIN/GR-Ob strain. Atherosclerosis 204: 136-140.
37. Zhang L, Geng Y, Xiao N, Yin M, Mao L, et al. (2009) High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. J Atheroscler Thromb 16: 463-471.
38. Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, et al. (2007) Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 191: 11-21.
39. Ji Y, Jian B, Wang N, Sun Y, Moya ML, et al. (1997) Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272: 20982-20985.
40. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, et al. (2005) Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 115: 2870-2874.
41. Vaysse-Boue C, Dabadie H, Peuchant E, Le Ruyet P, Mendy F, et al. (2007) Moderate dietary intake of myristic and alpha-linolenic acids increases lecithin-cholesterol acyltransferase activity in humans. Lipids 42: 717-722.
42. Parks JS, Bullock BC, Rudel LL, (1989) The reactivity of plasma phospholipids with lecithin:cholesterol acyltransferase is decreased in fish oil-fed monkeys. J Biol Chem 264: 2545-2551.
43. Yvan-Charvet L, Ranalletta M, Wang N, Han S, Terasaka N, et al. (2007) Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 117: 3900-3908.
44. Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, et al. (2010) Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction. Diabetes Care 33: 869-874.
45. von Eckardstein A, Sibler RA, (2011) Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol 22: 26-32.
46. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, et al. (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885-888.
47. Thomas TR, Smith BK, Donahue OM, Altena TS, James-Kracke M, et al. (2004) Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractions. Metabolism 53: 749-754.
48. Sugano M, Makino N, Yanaga T, (1997) Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits. Biochim Biophys Acta 1346: 17-24.
49. Abbey M, Clifton P, Kestin M, Belling B, Nestel P, (1990) Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10: 85-94.
50. Pawar A, Botolin D, Mangelsdorf DJ, Jump DB, (2003) The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J Biol Chem 278: 40736-40743.
51. Wang LJ, Song BL, (2012) Niemann-Pick C1-Like 1 and cholesterol uptake. Biochim Biophys Acta 1821: 964-972.
52. Lecker JL, Matthan NR, Billheimer JT, Rader DJ, Lichtenstein AH, (2011) Changes in cholesterol homeostasis modify the response of F1B hamsters to dietary very long chain n-3 and n-6 polyunsaturated fatty acids. Lipids Health Dis 10: 186.
53. Chen J, Jiang Y, Liang Y, Tian X, Peng C, et al. (2012) DPA n-3, DPA n-6 and DHA improve lipoprotein profiles and aortic function in hamsters fed a high cholesterol diet. Atherosclerosis 221: 397-404.
54. Mathur SN, Watt KR, Field FJ, (2007) Regulation of intestinal NPC1L1 expression by dietary fish oil and docosahexaenoic acid. J Lipid Res 48: 395-404.
55. Alvaro A, Rosales R, Masana L, Vallve JC, (2010) Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem 21: 518-525.
56. Zilversmit DB, (1983) A model for cholesterol absorption: isotope vs. mass; single dose vs. constant infusion. J Lipid Res 24: 297-302.
57. Jonkers IJ, Smelt AH, Princen HM, Kuipers F, Romijn JA, et al. (2006) Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia. J Nutr 136: 987-991.
58. Berard AM, Dumon MF, Darmon M, (2004) Dietary fish oil up-regulates cholesterol 7alpha-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion. FEBS Lett 559: 125-128.